Kymera Therapeutics Inc (KYMR)
EBITDA Growth
20.59%
Quarterly · Period ending:
KYMR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported20.59%period ending
Latest reported20.59%period ending
KYMR Quarterly EBITDA YoY % (33.66% → 20.59%)
Year-over-year change
High-resolution chart · PNG
KYMR ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 20.588% | |
| -5.8146% | |
| -23.9368% | |
| -32.4057% | |
| -85.7624% | |
| -34.9459% | |
| -411.7765% | |
| -16.3852% | |
| -5.844% | |
| -17.5851% | |
| 60.5019% | |
| -23.0622% | |
| 4.2014% | |
| -11.2304% | |
| -2.4938% | |
| -51.5714% | |
| -64.0822% | |
| -186.1372% | |
| -172.6914% | |
| -272.804% | |
| -77.3849% | |
| -19.5509% | |
| -9.3418% | |
| 33.6649% |